Challenges and Opportunities with Aldehyde Oxidase

Q2 Solutions offers complete bioanalytical and ADME solutions for testing around the globe and across the product development spectrum.  We combine knowledge from the collective services provided by our central labs, bioanalytical and ADME labs network, as well as integration into Quintiles global early clinical Phase I unit.  Presented at the 2015 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, this presentation details the challenges and opportunities with aldehyde oxidase, such as accurately predicting human clearance. Download now to learn more.

J Matthew Hutzler, Ph.D, Director of In Vitro Metabolism, Bioanalytical and ADME Labs